Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Berk

Showing results (51-60 of 1,304) with videos related to

Pageof 131
Sort By:
Human Psychopharmacology|May 27, 2003
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trialDora Wynchank, Michael Berk
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 22, 2022
Early intervention comes lateEduard Vieta, Michael Berk
The Journal of Clinical Psychiatry|January 7, 2011
The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?Lesley Stafford, Michael Berk
Expert Opinion on Drug Safety|May 25, 2004
The pharmacology of bipolar disorder during pregnancy and breastfeedingSeetal Dodd, Michael Berk
Bipolar Disorders|January 19, 2005
Bipolar II disorder: a reviewMichael Berk, Seetal Dodd
Drugs|January 6, 2005
Efficacy of atypical antipsychotics in bipolar disorderMichael Berk, Seetal Dodd
Journal of Affective Disorders|December 15, 2015
Theory of mind in major depressive disorder: A meta-analysisEmre Bora, Michael Berk
The Australian and New Zealand Journal of Psychiatry|July 15, 2017
Clinical research and the medical research future fundMichael Berk, Rob Ramsay
Evidence-Based Mental Health|April 28, 2006
Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depressionSeetal Dodd, Michael Berk
The Australian and New Zealand Journal of Psychiatry|April 10, 2013
Is 'depression' the new 'neurosis'?Michael Berk, Lesley Berk
Pageof 131

Showing results (51-60 of 1,304) with videos related to

Sort By:
Pageof 131
Human Psychopharmacology|May 27, 2003
Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trialDora Wynchank, Michael Berk
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 22, 2022
Early intervention comes lateEduard Vieta, Michael Berk
The Journal of Clinical Psychiatry|January 7, 2011
The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression?Lesley Stafford, Michael Berk
Expert Opinion on Drug Safety|May 25, 2004
The pharmacology of bipolar disorder during pregnancy and breastfeedingSeetal Dodd, Michael Berk
Bipolar Disorders|January 19, 2005
Bipolar II disorder: a reviewMichael Berk, Seetal Dodd
Drugs|January 6, 2005
Efficacy of atypical antipsychotics in bipolar disorderMichael Berk, Seetal Dodd
Journal of Affective Disorders|December 15, 2015
Theory of mind in major depressive disorder: A meta-analysisEmre Bora, Michael Berk
The Australian and New Zealand Journal of Psychiatry|July 15, 2017
Clinical research and the medical research future fundMichael Berk, Rob Ramsay
Evidence-Based Mental Health|April 28, 2006
Olanzapine plus fluoxetine reduce depressive symptoms faster than either drug alone in people with treatment resistant depressionSeetal Dodd, Michael Berk
The Australian and New Zealand Journal of Psychiatry|April 10, 2013
Is 'depression' the new 'neurosis'?Michael Berk, Lesley Berk
Pageof 131